About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Intelligent Hypertension Intervention Study

Intelligent Hypertension Intervention Study

NCT05526300·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Shanghai Tong Ren Hospital

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Aged more than 18 years old, less than or equal to 75 years old.
2. Hypertensive patients (systolic/diastolic blood pressure ≥140/90 mmHg at two separate screening/baseline visits)
3. Patients or guardians can skillfully use devices such as smartphones and electronic sphygmomanometers
4. Voluntarily joined and signed the informed consent

You may not be if

1. Pregnant women or women planning to become pregnant within the next year;
2. Patients with secondary hypertension
3. Patients with life expectancy less than 1 year
4. Severe hepatic and renal insufficiency (ALT \> 5 times ULA, eGFR \< 15ml/min/1.73mm2)
5. Known active malignancy disease
6. The researcher believes that patients who are not suitable to participate in this study

The record

StatusCompleted

PhaseNo phase

Taking part320

StartedSep 2022

UpdatedMay 21, 2025

Where3

Shanghai tongren hospital
Shanghai, Shanghai Municipality, China
Shanghai Fifth Rehabilitation Hospital
Shanghai, China
Songjiang hospital, Shanghai jiaotong University, School of medicine
Shanghai, China